Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00916435 · ClinicalTrials.gov registry record
Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 630
- Enrollment target
NCT00916435: Completed study, sponsored by Johns Hopkins University.
NCT00916435 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 630 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00916435 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 630 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: * to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and * to predict progression of heart failure in patients with ICD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-12 |
What the finished NCT00916435 record still lists
NCT00916435 is an observational study that tracks outcomes without assigning an intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00916435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00916435 about?
NCT00916435 is a clinical study titled "Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms". The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: * to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and * to predict progression of heart failure in patients with ICD.
What is the current status of trial NCT00916435?
This trial is currently completed. The enrollment target is 630 participants. The study started on 2005-03. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00916435?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia